Aurobindo Pharma USA Inc recalls Dicyclomine Hydrochloride Capsules
- Recalling company
- Aurobindo Pharma USA Inc
- Product
- Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
- Reason
- shortfill; reports of empty capsules.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jul 23, 2026
- Reported
- Aug 12, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 6,408 bottles distributed to market
- Lot / codes
- Batch # DMC125018A, Exp Date: 07/2027.
- Company location
- East Windsor, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0733-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0733-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.